<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of the immune system in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) progression has been widely accepted, although mechanisms underlying this <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune dysfunction</z:e> are not clear </plain></SENT>
<SENT sid="1" pm="."><plain>CD4(+) and CD8(+) lymphocyte profiles in the peripheral blood of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were evaluated and correlated with clinical characteristics, the expression of FOXP3 and the anti-inflammatory cytokines IL10, TGFÎ²1 and CTLA4 </plain></SENT>
<SENT sid="2" pm="."><plain>IL10 expression inversely correlated with the percentage of CD8(+) cells and was higher in high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Our findings provide further evidence for the role of T cell-mediated IL10 production in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and strengthen the idea of distinct cytokine profiles in low and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>